---
title: "neomycin - Hepatic encephalopathy"
sidebar: mydoc_sidebar
permalink: neomycinhepaticencephalopathy2.html
toc: false 
---

{% include image.html url="images/neomycinhepaticencephalopathy2.png" file="neomycinhepaticencephalopathy2.png" alt="neomycinhepaticencephalopathy2" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D009355 | neomycin | Drug |
| MESH:D012336 | RNA, Ribosomal, 16S | CellularComponent |
| GO:0048027 | mRNA 5-UTR binding | MolecularActivity |
| NCBITaxon:562 | Escherichia coli | OrganismTaxon |
| GO:0097272 | ammonium homeostasis | BiologicalProcess |
| GO:0097272 | ammonium homeostasis | BiologicalProcess |
| HP:0001987 | Hyperammonemia | PhenotypicFeature |
| MESH:D006501 | Hepatic encephalopathy | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Neomycin | DECREASES ACTIVITY OF | Rna, Ribosomal, 16S |
| Rna, Ribosomal, 16S | PARTICIPATES IN | Mrna 5-Utr Binding |
| Mrna 5-Utr Binding | IN TAXON | Escherichia Coli |
| Escherichia Coli | CORRELATED WITH | Ammonium Homeostasis |
| Ammonium Homeostasis | PREVENTS | Hyperammonemia |
| Hyperammonemia | CAUSES | Hepatic Encephalopathy |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB00994#mechanism-of-action](https://go.drugbank.com/drugs/DB00994#mechanism-of-action){:target="_blank"}